Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure (TXACOVIDPREV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04550338

Recruitment Status : Withdrawn (With vaccination efforts ongoing, a feasibility survey indicated there would be inadequate recruitment)

First Posted : September 16, 2020

Last Update Posted : April 23, 2021

Sponsor:

Information provided by (Responsible Party):

Timothy Ness, MD, University of Alabama at Birmingham

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Withdrawn
Estimated Primary Completion Date :	December 31, 2022
Estimated Study Completion Date :	March 31, 2023

To Top